Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly PDF Brochure Send to Friend Enquire before Buying Hard Copy Electronic Site License Icact 2001: Highlights of Trial Results, Discussions and Commercial Implications Datamonitor, Feb 2001   Description     Table of Contents        Enquire before Buying    Send to a Friend   Already established as the treatment of choice for metastatic breast cancer, strong results from US trials have seen the taxanes surge into the adjuvant setting. Within Europe however, the taxanes are unlikely to be incorporated into treatment patterns for localized disease before the results of key clinical trials become available. This brief reviews the major trial releases and topics of discussion from the International Conference of Anti-Cancer Treatment, 6-9 February 2001, including current issues in the treatment of solid tumor and hematological malignancies, as well as updates on the progress of novel agents, such as Iressa, Faslodex and rhuMAb Vegf, through clinical trials. Customers who bought this item also bought Drug Transporters and ADME: Pharmacological and Commercial Implications Successfully Marketing Clinical Trial Results Anti-hypertensives: Landmark clinical trial update - Commercial assessment of Charm, Comet, Ephesus and Europa Proactive Results - The Diabetes Trial That Could Have Been H1 2001 Results: Financial Results of the Top 12 Pharmaceutical Companies 2001 Results: Financial Results of the Top 16 Pharmaceutical and Biotechnology Companies Optimizing the Clinical Trial Process: Strategies to Reduce Costs and Increase Quality Optimizing the Clinical Trial Process: Strategies to Reduce Costs and Increase Quality

		Top of page

All rights reserved. � Copyright 2008 Research and Markets    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster